SCHEMBL17872161

SCHEMBL17872161

CN(C)CC(NC(=O)N1Cc2c(Nc3cccc(NC(=O)c4ccc([N+](=O)[O-])cc4)c3)nn(C(=O)O)c2C1(C)C)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK7 P50613 9/20 0.58
CCNH P51946 9/20 0.58
MNAT1 P51948 9/20 0.58
CDK2 P24941 3/20 0.58
MELK Q14680 3/20 0.58
HIPK4 Q8NE63 1/20 0.58
PAK4 O96013 11/20 0.51
CCNT1 O60563 1/20 0.48
CCNA2 P20248 1/20 0.48
CDK9 P50750 1/20 0.48
CCNA1 P78396 1/20 0.48
MAPK1 P28482 2/20 0.43
RPS6KA1 Q15418 2/20 0.43
PLK4 O00444 1/20 0.41
CHEK1 O14757 1/20 0.41
AURKA O14965 1/20 0.41
GAK O14976 1/20 0.41
RPS6KA5 O75582 1/20 0.41
RPS6KA4 O75676 1/20 0.41
STK16 O75716 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20741127 1.00 CDK7 (0.58) CDK7CCNHMNAT1CDK2MELK
SCHEMBL20741131 1.00 CDK7 (0.58) CDK7CCNHMNAT1CDK2MELK
SCHEMBL31220806 0.93 CDK7 (0.56) CDK7CCNHMNAT1CDK2MELK
SCHEMBL17872160 0.92 CDK7 (0.50) CDK7CCNHMNAT1CDK2MELK
SCHEMBL20741173 0.92 CDK7 (0.61) CDK7CCNHMNAT1CDK2MELK
SCHEMBL17872104 0.92 CDK7 (0.61) CDK7CCNHMNAT1CDK2MELK
SCHEMBL20741164 0.88 CDK7 (0.76) CDK7CCNHMNAT1CDK2MELK
SCHEMBL17872117 0.88 CDK7 (0.76) CDK7CCNHMNAT1CDK2MELK
SCHEMBL23260155 0.86 CDK7 (0.78) CDK7CCNHMNAT1CDK2MELK
SCHEMBL31220748 0.85 CDK7 (0.58) CDK7CCNHMNAT1CDK2MELK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3236959-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) Dana Farber Cancer Institute, Inc. (US) 2017-11-01 EP disclosed
WO-2016105528-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) DANA-FARBER CANCER INSTITUTE, INC. (US) 2016-06-30 WO disclosed